
Milk made from yeast rather than animals or plants developed in Japan
It's unclear at exactly what point we as humans started to drink cow's milk, but it has since firmly entrenched itself as a key food in our daily lives, whether drunk straight, fermented into other dairy foods like cheese, butter, and yogurt, or as an ingredient in a range of things from fine cuisine to cups of coffee.
But it's not without its setbacks. Many people still have trouble digesting the lactose or have a dangerous allergy to it, and others refrain out of ethical concerns related to the milking of cattle. Alternatives like soy milk and almond milk exist, but they never really taste the same and are more of their own drinks than actual substitutes.
But now, major beverage maker Asahi believes they have concocted a worthy alternative to cow's milk that is not only non-allergenic but also ethically produced to meet everyone's dietary needs. Rather than animals or plants, Like Milk is derived from microorganisms for both taste and nutrition that rivals and surpasses that of other milk products.
Asahi has been researching the yeast it uses to make beer for nearly a century now, and has finally found a way to retain the protein, vitamins, and other nutrients it contains while giving it the mellow sweetness and creamy texture milk is known for. As a result, Like Milk has more dietary fiber and zinc than either cow milk or soy milk and also has 38 percent less fat than whole cow's milk, while also being free of all 28 standard allergy-causing ingredients.
▼ The following chart shows the comparative values of energy, protein, fat, cholesterol, carbohydrates, digestible carbs, dietary fiber, calcium, and zinc in that order.
Speaking of dietary fiber, Asahi warns drinkers that this milk is a lot higher in fiber than you might expect, so don't go chugging a liter of Like Milk in one sitting unless you enjoy spending time on the toilet. It's also slightly brown due to its unique creation and, unlike regular milk, it can be stored at room temperature for about six months if unopened, making it a handy, nutritious drink to keep in a disaster preparedness kit.
▼ It's a neutral color that blends in well with most home decor.
Unfortunately, Like Milk is not at the mass production stage yet, so only limited quantities are being sold at this time. Asahi recently offered a batch on Japanese crowdfunding site Makuake and sold 2.2 million yen worth of it. They also had samples at the Vegan Gourmet Matsuri in Tokyo, where it got an 80-percent 'delicious' rating.
Asahi plans to sell a limited run of one-liter cartons this fall and then hopes to get mass production underway sometime next year. They also hinted at research on a Like Egg product based on similar principles. In the meantime, if you can get your hands on some Like Milk to try it, consider yourself lucky, especially if you normally forego milk for health or ethical reasons.
Source: Like Milk, PR Times, Huffington Post Japan, Makuake
Images: PR Times, Makuake
Read more stories from SoraNews24.
-- Sake milk shakes return to Japan's Mos Burger with the Shinsei Dassai Mazeru Shake
-- 23 flavors, five top recommendations for the wide world of Kikkoman soy milk【Taste test】
-- How to make so, Japan's 1,000-year-old dessert recipe that's back in fashion【SoraKitchen】
External Link
https://soranews24.com/2025/07/10/milk-made-from-yeast-rather-than-animals-or-plants-developed-in-japan/
© SoraNews24

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

5 hours ago
Survey in Japan Finds Majority of People Sleep with AC on in Summer
Japan Data Lifestyle Health Aug 7, 2025 In Japan's hot summers, more than half of people leave the air conditioner on through the night. A survey in Japan found that 92.5% of the respondents have an air conditioner in their home, and that 38.1% of them always turn it off when going out during the summer. The survey was conducted by market research firm Cross Marketing, targeting people nationwide aged 20 to 69, with a total of 1,100 valid responses received. Among those surveyed, 56.4% said that they leave their air conditioner on throughout the night. All age groups were above 50%, with especially high rates among those in their twenties and thirties, at 59.0% and 58.2%, respectively. With Japan continuing to face severe heatwaves every summer, the habit of cooling down a room even when outside the home or asleep is becoming the norm among more and more people. According to the survey results, the most common temperature setting is between 26.0 ° and 27.5 ° Celsius during the day, and between 27.0 ° and 28.5 ° at night. Data Sources (Translated from Japanese. Banner photo © Pixta.) summer heatstroke

9 hours ago
Japan OKs Price Cut for Alzheimer's Drug Lecanemab
News from Japan Aug 6, 2025 20:15 (JST) Tokyo, Aug. 6 (Jiji Press)--A Japanese health ministry panel Wednesday approved a plan to cut the price of Lecanemab, an Alzheimer's drug codeveloped by Japanese drugmaker Eisai Co. and U.S. industry peer Biogen Inc., by 15 pct in Japan starting Nov. 1. The decision is based on an assessment by the Central Social Insurance Medical Council that cited the low cost-effectiveness of the drug used to treat dementia caused by Alzheimer's disease. The price of the drug will be lowered to 97,277 yen for a 500-milligram bottle. Dosages are based on weight. For example, a patient weighing 50 kilograms would see an annual cost reduction from about 2.98 million yen to about 2.53 million yen. Lecanemab is said to be innovative because it removes abnormal proteins that accumulate in patients' brains, and is expected to slow the progression of the disease. The medication was subject to a system that adjusts drug prices based on cost-effectiveness for high-priced or large-market drugs. [Copyright The Jiji Press, Ltd.] Jiji Press


Nikkei Asia
a day ago
- Nikkei Asia
Sumitomo Pharma files for approval of stem cell Parkinson's treatment
Induced pluripotent stem cell technology was developed in Japan in 2007, but progress on developing treatments for diseases has been slow. (Photo obtained by Nikkei) NANAKO TAKEUCHI, YUKI MISUMI and AKANE ASAMI OSAKA/TOKYO -- Japanese drugmaker Sumitomo Pharma has applied for approval in Japan of a stem cell-based Parkinson's disease treatment, it announced on Tuesday, looking to ease the motor symptoms of sufferers and help push the country's stem cell treatment implementation forward.